Tat is one of the regulatory proteins of the HIV-1 virus. To date, bes
ides the transactivation activity, a myriad of effects exerted by HN-I
Tat on cellular and viral genes have been observed. The present study
investigated the in vivo effects of HIV-1 Tat protein in the Xenopus
embryo. We adopted the Xenopus system since expression of putative reg
ulatory factors in the embryo has been widely used as a quick and effe
ctive first screen for protein function. Xenopus' early development is
well characterized by stage-specific phenotypes, therefore, an in viv
o HIV-1 Tat-mediated aberrant phenotype can easily be detected and ana
lyzed. HIV-1 Tat protein expression through injection of synthetic mRN
A into zygotes produced a marked delay in gastrulation leading to alte
red specification of the anterior-posterior axis and to partial or tot
al loss of anterior structures. HIV-1 Tat effects resulted in a genera
l suppression of gene expression, including that of Xbra and gsc, two
early genes whose expression is required for proper gastrulation. The
specificity of Tat effects was demonstrated by injecting a 'loss of fu
nction' mutant (Tat-C37S), lacking a single cysteine residue, which di
d not yield any effect. Both Tat and Tat-C37S were found to be localiz
ed mainly in the nucleus. The importance of subcellular targeting for
the effects caused by HIV-1 Tat was demonstrated by injecting a second
mutant (Tat-BDM), carrying an altered nuclear localization signal seq
uence. The Tat-BDM protein localized in the cytoplasm and accumulated
at the cell membrane. Embryos injected with Tat-BDM mRNA did not devel
op beyond gastrulation. The importance of proper protein conformation
and subcellular localization in determining Tat effects is discussed.